Perrigo Gains Pole Position In Private-Label Allegra Race
This article was originally published in The Tan Sheet
Executive Summary
Perrigo cuts to the front of the queue for launching private-label versions of OTC Allegra, acquiring from Teva the exclusive U.S. sales and distribution rights to generic equivalents of the allergy drug
You may also be interested in...
In Brief
Dr. Reddy’s launches Allegra-D equivalent
In Brief
Dr. Reddy’s launches Allegra-D equivalent
Perrigo Takes Two Steps Forward: Generic Allegra Launch, Manufacturing Compliance
Perrigo stokes momentum behind already healthy sales growth with significant steps in separate areas: a green light for regulatory compliance at its main manufacturing plant, and the launch of its generic OTC versions of Sanofi-Aventis' Allegra.